#1 Clinical Trials Search in Europe

Calcifediol

Calcifediol, a form of vitamin D, is being studied in various clinical trials for its potential benefits in treating and preventing different health conditions. These trials aim to evaluate the efficacy and safety of calcifediol supplementation in conditions ranging from COVID-19 to asthma and vitamin D deficiency. The research explores how calcifediol may impact disease outcomes, improve vitamin D status, and affect various health markers.

Table of Contents

What is Calcifediol?

Calcifediol, also known as 25-hydroxyvitamin D or 25(OH)D, is a form of vitamin D that plays a crucial role in our body’s vitamin D system[1]. It’s sometimes referred to as a “prohormone,” which means it’s a substance that can be converted into an active hormone in our body[1]. Calcifediol is the cornerstone of our vitamin D endocrine system and serves as the substrate (starting material) for the synthesis of calcitriol, which is the active hormone form of vitamin D[1].

Conditions Treated with Calcifediol

Calcifediol is being studied and used to treat various conditions, including:

  • Vitamin D Deficiency: This is one of the primary uses of calcifediol. It’s especially useful in people who have trouble absorbing or processing regular vitamin D supplements[2].
  • COVID-19: Researchers are investigating whether calcifediol can help prevent or reduce the severity of COVID-19, particularly in reducing the risk of severe respiratory problems and death[1][3].
  • Secondary Hyperparathyroidism in Kidney Transplant Patients: This is a condition where the parathyroid glands produce too much hormone, often due to kidney problems[4].
  • Asthma: Some studies are looking at whether calcifediol can help improve asthma control in patients who are deficient in vitamin D[5].
  • Heart Health: Researchers are studying if calcifediol can help improve heart function after a heart attack[6].
  • Acute Kidney Injury: There’s ongoing research to see if calcifediol can help prevent or reduce the severity of sudden kidney damage in critically ill patients[7].

How Calcifediol Works

Calcifediol works by increasing the levels of active vitamin D in your body. Unlike regular vitamin D supplements, calcifediol doesn’t need to be processed by your liver before it can be used[1]. This makes it especially useful for people who have liver problems or other conditions that make it hard for their bodies to activate regular vitamin D.

When you take calcifediol, it quickly raises the levels of 25-hydroxyvitamin D in your blood. This can then be converted to the active form of vitamin D (calcitriol) in various parts of your body where it’s needed[1]. The active vitamin D can then help with many important functions, including:

  • Helping your body absorb calcium from food
  • Supporting your immune system
  • Reducing inflammation
  • Helping to regulate cell growth

Administration and Dosage

Calcifediol is typically taken orally (by mouth) in the form of capsules or drops. The dosage can vary depending on the condition being treated and the individual patient’s needs. Some common dosing regimens seen in research studies include:

  • Weekly doses ranging from 75 to 125 micrograms[2]
  • Monthly doses of about 266 micrograms[3]
  • Daily doses ranging from 10 to 20 micrograms[8]

It’s important to note that calcifediol should only be taken under the guidance of a healthcare provider, as the correct dose can vary based on your individual needs and medical condition.

Ongoing Research and Potential Benefits

Researchers are actively studying calcifediol for various potential benefits:

  • COVID-19 Treatment: Some studies suggest that calcifediol might help reduce the severity of COVID-19 and lower the risk of needing intensive care or dying from the disease[1][3].
  • Heart Health: Researchers are investigating whether calcifediol can help improve heart function and reduce damage after a heart attack[6].
  • Kidney Health: Studies are looking at whether calcifediol can help prevent or reduce the severity of sudden kidney damage in critically ill patients[7].
  • Asthma Control: Some research is exploring whether calcifediol supplementation can help improve asthma control in patients with vitamin D deficiency[5].
  • Bone Health: Calcifediol may help improve bone density and reduce the risk of falls in older adults[8].

Side Effects and Safety

While calcifediol is generally considered safe when used as directed, it can have side effects. Common side effects may include:

  • Nausea
  • Constipation
  • Increased thirst
  • Increased urination

In some cases, calcifediol can cause more serious side effects, especially if taken in high doses. These can include:

  • High calcium levels in the blood (hypercalcemia)
  • Kidney problems
  • Increased risk of kidney stones

It’s important to take calcifediol only as prescribed by your healthcare provider and to have regular blood tests to monitor your vitamin D and calcium levels while taking this medication[2][7].

Condition Study Design Intervention Primary Outcomes
COVID-19 Randomized, double-blind, placebo-controlled Calcifediol (various dosing regimens) Mortality rate, ICU admission, resolution of symptoms
Vitamin D Deficiency Randomized, double-blind, dose-ranging Calcifediol soft gelatin capsules (various doses) Percentage of subjects achieving target 25-OH-D levels
Asthma Randomized, triple-blind, controlled Calcifediol (Hidroferol®) 16,000 IU weekly Asthma control measured by Asthma Control Test (ACT)
Secondary Hyperparathyroidism (post-kidney transplant) Randomized, controlled Paricalcitol vs. Calcifediol Control of iPTH levels
Myocardial Infarction Randomized, double-blind, placebo-controlled Calcifediol 15,690 IU every two weeks Change in cardiac remodeling by MRI

FAQ

  • What is calcifediol and how does it differ from other forms of vitamin D? Calcifediol is a form of vitamin D also known as 25-hydroxyvitamin D. It is more readily absorbed by the body compared to other forms of vitamin D, such as vitamin D3. Calcifediol does not require liver processing, making it potentially more effective in quickly raising vitamin D levels in the body.
  • In which health conditions is calcifediol being studied? Calcifediol is being studied in various health conditions, including COVID-19, vitamin D deficiency, asthma, secondary hyperparathyroidism in kidney transplant patients, and myocardial infarction. Researchers are exploring its potential benefits in improving disease outcomes and overall health status in these conditions.
  • How is calcifediol administered in clinical trials? The administration of calcifediol varies across trials. Some studies use oral capsules or soft gelatin capsules, while others use oral drops. The dosage and frequency of administration differ based on the specific trial and condition being studied. For example, some trials use weekly doses, while others use monthly or daily regimens.
  • What are some potential benefits of calcifediol supplementation being investigated? Researchers are investigating various potential benefits of calcifediol supplementation, including improved vitamin D status, reduced risk of COVID-19 complications, better asthma control, improved outcomes after myocardial infarction, and enhanced management of secondary hyperparathyroidism in kidney transplant patients. Some studies also explore its effects on bone health, muscle function, and overall quality of life.
  • Are there any safety concerns associated with calcifediol supplementation? While calcifediol is generally considered safe, clinical trials monitor for potential adverse effects. Some studies specifically assess safety outcomes such as changes in serum calcium levels, kidney function, and the occurrence of hypercalcemia. It's important to note that calcifediol supplementation should be done under medical supervision, especially in clinical trial settings.

Ongoing Clinical Trials on Calcifediol

  • Study of calcifediol treatment to improve vitamin D levels in adults with pulmonary arterial hypertension

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness of Cholecalciferol and Calcifediol in Treating Severe Vitamin D Deficiency in Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Calcifediol: A form of vitamin D also known as 25-hydroxyvitamin D, which is more readily absorbed by the body compared to other forms of vitamin D.
  • Vitamin D deficiency: A condition where the body doesn't have enough vitamin D, which can lead to various health issues including weakened bones and immune system.
  • Secondary hyperparathyroidism: A condition where the parathyroid glands produce excess parathyroid hormone, often as a result of kidney disease or vitamin D deficiency.
  • Myocardial infarction: Commonly known as a heart attack, it occurs when blood flow to the heart is blocked, causing damage to the heart muscle.
  • Asthma: A chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties.
  • COVID-19: An infectious disease caused by the SARS-CoV-2 virus, which can lead to respiratory symptoms and other health complications.
  • Serum 25-hydroxyvitamin D: A blood test used to measure vitamin D levels in the body, which is the primary form of vitamin D circulating in the bloodstream.
  • Paricalcitol: A synthetic vitamin D analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease.
  • Intact parathyroid hormone (iPTH): A hormone produced by the parathyroid glands that regulates calcium levels in the blood.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Cytokine storm: An severe immune reaction where the body releases too many inflammatory proteins called cytokines, which can lead to organ damage.
  • Acute respiratory distress syndrome (ARDS): A severe lung condition characterized by rapid onset of widespread inflammation in the lungs, leading to difficulty breathing.

References

  1. https://clinicaltrials.gov/study/NCT06279910
  2. https://clinicaltrials.gov/study/NCT04735926
  3. https://clinicaltrials.gov/study/NCT04366908
  4. https://clinicaltrials.gov/study/NCT01939977
  5. https://clinicaltrials.gov/study/NCT02805907
  6. https://clinicaltrials.gov/study/NCT02548364
  7. https://clinicaltrials.gov/study/NCT02962102
  8. https://clinicaltrials.gov/study/NCT01017354